Long Term Evaluation of Primary Congenital Glaucoma Management in Sohag University Hospital

Overview

evaluation of primary congenital glaucoma management in sohag university hospital

Full Title of Study: “Long Term Evaluation of Primary Congenital Glaucoma Management In Sohag University Hospital”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: March 1, 2022

Detailed Description

long term evaluation of primary congenital glaucoma management in sohag university hospital

Interventions

  • Other: Primary congenital glaucoma evaluation
    • long term evaluation of primary congenital glaucoma management

Clinical Trial Outcome Measures

Primary Measures

  • evaluation of patient with primary congenital glaucoma managed in sohag university hospital by surgical intervention,trabeculectomy and trabecultomy with mitomycin and ologen.follow up after management by measuring intra ocular pressure by Perkins.
    • Time Frame: 3years
    • retrospective study

Participating in This Clinical Trial

Inclusion Criteria

  • children operated more than 3 months Exclusion Criteria:

  • other types of operated pediatric glaucoma

Gender Eligibility: All

Minimum Age: 3 Months

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Sohag University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Ghada Fathy Mohamed, resident practitioner of ophthalmology.principal investigator – Sohag University
  • Overall Official(s)
    • ghada f mohamed, MBBCH, Principal Investigator, Sohag University
  • Overall Contact(s)
    • Ghada f mohamed, MBBCH, 01004720821, ghada_fathy_post@med.sohag.edu.eg

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.